Filing Details
- Accession Number:
- 0001209191-20-032794
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-28 20:26:34
- Reporting Period:
- 2020-05-16
- Accepted Time:
- 2020-05-28 20:26:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339970 | Atyr Pharma Inc | LIFE | Biological Products, (No Disgnostic Substances) (2836) | 203435077 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1640869 | Nancy Denyes | 3545 John Hopkins Court, Suite 250 San Diego CA 92121 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-16 | 892 | $0.00 | 3,057 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-20 | 322 | $3.62 | 2,735 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2020-05-26 | 30,000 | $0.00 | 30,000 | $4.06 |
| Common Stock | Restricted Stock Unit | Disposition | 2020-05-16 | 892 | $0.00 | 892 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 30,000 | 2030-05-26 | No | 4 | A | Direct | |
| 0 | No | 4 | M | Direct |
Footnotes
- Restricted stock units (RSU) convert into common stock on a one-for-one basis.
- Includes 178 shares acquired under the Company's 2015 Employee Stock Purchase Plan (ESPP) on May 15, 2020.
- Sale made by the Reporting Person in compliance with the provisions of Rule 10b5-1 to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on May 16, 2018.
- 50% of the shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 26, 2020, such that these shares will be fully exercisable on May 26, 2024; 25% of the shares subject to this option will vest on May 26, 2021 if and only if a clinical development milestone is achieved by September 30, 2020; and the remaining 25% of the shares will vest on May 26, 2021 if and only if an additional clinical development milestone is achieved by September 30, 2020.
- The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on May 16, 2019.
Billionaire Hedge Funds
